Shares of Abbott Labs (ABT -1.9%) slide after the National Institutes of Health stops a clinical...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Shares of Abbott Labs (ABT -1.9%) slide after the National Institutes of Health stops a clinical trial early that was looking at cholesterol treatments after finding that the company's drug Niaspan doesn't reduce the risk of heart attacks and strokes. "It would be premature to extrapolate these results to a broader patient population at this time," Abbott says (PR).